Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Turck

Showing results (181-190 of 462) with videos related to

Pageof 47
Sort By:
EFSA Journal. European Food Safety Authority|September 3, 2020
Coffee C21 and protection of DNA from strand breaks: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Jacqueline Castenmiller, et al.
Inflammatory Bowel Diseases|January 1, 2005
Efficacy and tolerance of infliximab in children and adolescents with Crohn's diseaseThierry Lamireau, Jean-Pierre Cézard, Alain Dabadie, et al.
EFSA Journal. European Food Safety Authority|July 5, 2024
Joselito® and lowering of LDL-cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|May 24, 2024
Scientific Opinion on additional scientific data related to the safety of preparations of <i>Rheum palmatum</i> L., <i>Rheum officinale</i> Baill. and their hybrids, <i>Rhamnus purshiana</i> DC., <i>Rhamnus frangula</i> L. and <i>Cassia senna</i> L., submitted pursuant to Article 8(4) of Regulation (EC) No 1925/2006, Dominique Turck, Torsten Bohn, et al.
Maternal & Child Nutrition|December 6, 2011
Re: ESPGHAN's 2008 recommendation for early introduction of complementary foods: how good is the evidence? (Cattaneo et al. 2011)Raanan Shamir, Berthold Koletzko, Carlo Agostoni, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
GlycoLite™ and helps to reduce body weight: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Jacqueline Castenmiller, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
A combination of beta-sitosterol and beta-sitosterol glucoside and normal function of the immune system: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Jacqueline Castenmiller, et al.
EFSA Journal. European Food Safety Authority|July 28, 2023
Choline and contribution to normal liver function of the foetus and exclusively breastfed infants: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|September 27, 2023
Re-evaluation of behenic acid from mustard seeds to be used in the manufacturing of certain emulsifiers pursuant to Article 21(2) of Regulation (EU) No 1169/2011 - for permanent exemption from labelling, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|September 3, 2020
Orodispersible lozenges containing a combination of <i>Lactobacillus reuteri</i> DSM 17938 and <i>Lactobacillus reuteri</i> ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Jacqueline Castenmiller, et al.
Pageof 47

Showing results (181-190 of 462) with videos related to

Sort By:
Pageof 47
EFSA Journal. European Food Safety Authority|September 3, 2020
Coffee C21 and protection of DNA from strand breaks: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Jacqueline Castenmiller, et al.
Inflammatory Bowel Diseases|January 1, 2005
Efficacy and tolerance of infliximab in children and adolescents with Crohn's diseaseThierry Lamireau, Jean-Pierre Cézard, Alain Dabadie, et al.
EFSA Journal. European Food Safety Authority|July 5, 2024
Joselito® and lowering of LDL-cholesterol concentration, blood pressure, and reduction of coronary heart disease risk: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|May 24, 2024
Scientific Opinion on additional scientific data related to the safety of preparations of <i>Rheum palmatum</i> L., <i>Rheum officinale</i> Baill. and their hybrids, <i>Rhamnus purshiana</i> DC., <i>Rhamnus frangula</i> L. and <i>Cassia senna</i> L., submitted pursuant to Article 8(4) of Regulation (EC) No 1925/2006, Dominique Turck, Torsten Bohn, et al.
Maternal & Child Nutrition|December 6, 2011
Re: ESPGHAN's 2008 recommendation for early introduction of complementary foods: how good is the evidence? (Cattaneo et al. 2011)Raanan Shamir, Berthold Koletzko, Carlo Agostoni, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
GlycoLite™ and helps to reduce body weight: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Jacqueline Castenmiller, et al.
EFSA Journal. European Food Safety Authority|July 7, 2020
A combination of beta-sitosterol and beta-sitosterol glucoside and normal function of the immune system: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Jacqueline Castenmiller, et al.
EFSA Journal. European Food Safety Authority|July 28, 2023
Choline and contribution to normal liver function of the foetus and exclusively breastfed infants: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|September 27, 2023
Re-evaluation of behenic acid from mustard seeds to be used in the manufacturing of certain emulsifiers pursuant to Article 21(2) of Regulation (EU) No 1169/2011 - for permanent exemption from labelling, Dominique Turck, Torsten Bohn, et al.
EFSA Journal. European Food Safety Authority|September 3, 2020
Orodispersible lozenges containing a combination of <i>Lactobacillus reuteri</i> DSM 17938 and <i>Lactobacillus reuteri</i> ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, Dominique Turck, Jacqueline Castenmiller, et al.
Pageof 47